M. Yokoyama et al., BETACELLULIN, A MEMBER OF THE EPIDERMAL GROWTH-FACTOR FAMILY, IS OVEREXPRESSED IN HUMAN PANCREATIC-CANCER, International journal of oncology, 7(4), 1995, pp. 825-829
Human pancreatic ductal adenocarcinomas overexpress the epidermal grow
th factor (EGF) receptor. Betacellulin is a mitogenic polypeptide that
binds and activates this receptor. To determine whether betacellulin
has a role in human pancreatic cancer, we studied its expression in cu
ltured human pancreatic cancer cell lines and in normal and cancerous
pancreatic tissues. Five of 6 pancreatic cancer cell lines expressed t
he 3 kb betacellulin mRNA moiety, T3M4, MiaPaCa-2 and COLO-357 cells e
xhibiting the highest expression levels. EGF, heparin-binding EGF-like
growth factor (HB-EGF), and basic fibroblast growth factor (bFGF) inc
reased betacelullin mRNA levels. Only 2 of 15 normal samples and 1 of
10 cancer samples failed to exhibit the betacellulin transcript. Densi
tometric analysis of the autoradiographs revealed a 7.5-fold increase
in betacellulin mRNA levels in the cancer tissues by comparison with t
he normal tissues. By in situ hybridization, the duct-like cancer cell
s exhibited many betacellulin mRNA in situ hybridization grains. These
findings indicate that human pancreatic cancer cells express betacell
ulin in culture and in vivo, and suggest that this EGF-like ligand may
participate in aberrant autocrine and paracrine activation of the EGF
receptor in human pancreatic cancer.